Chancery Finds Ex-CEO In Contempt In Biopharma IP Suit
Law360, Wilmington (May 22, 2019, 9:26 PM EDT) -- A biopharmaceutical company physician-investor was ruled in contempt Wednesday for failing to maintain the Delaware Chancery Court-ordered status quo in a suit challenging his transfer of all intellectual property from a venture he directed to one he created and purportedly controlled.
Vice Chancellor Joseph R. Slights III also took a motion from Macrophage Therapeutics Inc. under advisement asking for summary judgment against Dr. Michael M. Goldberg, its founder and former CEO, who is accused of wrongly moving its assets to a new company under his control and breaching his fiduciary duty and duties of care and loyalty. The company is also...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!